Salvage Treatment for Invasive Aspergillosis and Mucormycosis: Challenges, Recommendations and Future Considerations
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Salvage Treatment for Invasive Aspergillosis and Mucormycosis: Challenges, Recommendations and Future Considerations
Authors
Keywords
-
Journal
Infection and Drug Resistance
Volume Volume 16, Issue -, Pages 2167-2178
Publisher
Informa UK Limited
Online
2023-04-12
DOI
10.2147/idr.s372546
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Race and ethnicity: Risk factors for fungal infections?
- (2023) Jeffrey D. Jenks et al. PLoS Pathogens
- The current state of laboratory mycology in Asia/Pacific: A survey from the European Confederation of Medical Mycology (ECMM) and International Society for Human and Animal Mycology (ISHAM)
- (2023) Jon Salmanton-García et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Guideline adherence and survival of patients with candidaemia in Europe: results from the ECMM Candida III multinational European observational cohort study
- (2023) Martin Hoenigl et al. LANCET INFECTIOUS DISEASES
- Human Tissue Distribution of Caspofungin
- (2022) Jana Marx et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- The current state of clinical mycology in Africa: a European Confederation of Medical Mycology and International Society for Human and Animal Mycology survey
- (2022) Cândida Driemeyer et al. Lancet Microbe
- The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries
- (2022) Martin Hoenigl et al. Lancet Microbe
- Let's talk about sex characteristics—As a risk factor for invasive fungal diseases
- (2022) Matthias Egger et al. MYCOSES
- New Perspectives on Antimicrobial Agents: Isavuconazole
- (2022) James S. Lewis et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Combination Treatment of Fosmanogepix and Liposomal Amphotericin B Is Superior to Monotherapy in Treating Experimental Invasive Mold Infections
- (2022) Teclegiorgis Gebremariam et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Isavuconazole plasma concentrations in critically ill patients during extracorporeal membrane oxygenation
- (2022) Lisa Kriegl et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- COVID-19-associated fungal infections
- (2022) Martin Hoenigl et al. Nature Microbiology
- Ibrexafungerp, a Novel Triterpenoid Antifungal in Development for the Treatment of Mold Infections
- (2022) David A. Angulo et al. Journal of Fungi
- Liposomal amphotericin B—the future
- (2022) M Hoenigl et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Posaconazole versus voriconazole for primary treatment of invasive aspergillosis: a phase 3, randomised, controlled, non-inferiority trial
- (2021) Johan A Maertens et al. LANCET
- Posaconazole micelles for ocular delivery: in vitro permeation, ocular irritation and antifungal activity studies
- (2021) Meltem Ezgi Durgun et al. Drug Delivery and Translational Research
- In Vitro Activity of Ibrexafungerp against a Collection of Clinical Isolates of Aspergillus, Including Cryptic Species and Cyp51A Mutants, Using EUCAST and CLSI Methodologies
- (2021) Olga Rivero-Menendez et al. Journal of Fungi
- In Vitro Activity of Novel Antifungal Olorofim against Filamentous Fungi and Comparison to Eight Other Antifungal Agents
- (2021) Ourania Georgacopoulos et al. Journal of Fungi
- Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients—a multinational observational study by the European Confederation of Medical Mycology
- (2021) Juergen Prattes et al. CLINICAL MICROBIOLOGY AND INFECTION
- Combination treatment of liposomal amphotericin B and isavuconazole is synergistic in treating experimental mucormycosis
- (2021) Teclegiorgis Gebremariam et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- ECMM/ISHAM recommendations for clinical management of COVID‐19 associated mucormycosis in low‐ and middle‐income countries
- (2021) Shivaprakash M. Rudramurthy et al. MYCOSES
- Aspergillus fumigatus and aspergillosis: From basics to clinics
- (2021) A. Arastehfar et al. STUDIES IN MYCOLOGY
- Voriconazole plus terbinafine combination antifungal therapy for invasive Lomentospora prolificans infections: analysis of 41 patients from the FungiScope® registry 2008–2019
- (2020) J.D. Jenks et al. CLINICAL MICROBIOLOGY AND INFECTION
- Fosmanogepix (APX001) Is Effective in the Treatment of Pulmonary Murine Mucormycosis Due to Rhizopus arrhizus
- (2020) Teclegiorgis Gebremariam et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics and Pharmacodynamics of Posaconazole
- (2020) Lu Chen et al. DRUGS
- Breakthrough Invasive Fungal Infections: Who is at risk?
- (2020) Jeffrey D. Jenks et al. MYCOSES
- Isavuconazole Treatment in a Mixed Patient Cohort with Invasive Fungal Infections: Outcome, Tolerability and Clinical Implications of Isavuconazole Plasma Concentrations
- (2020) Christoph Zurl et al. Journal of Fungi
- Diagnosis of Breakthrough Fungal Infections in the Clinical Mycology Laboratory: An ECMM Consensus Statement
- (2020) Jeffrey D. Jenks et al. Journal of Fungi
- Mucormycosis in Hematopoietic cell Transplant Recipients and in patients with Hematological Malignancies in the Era of New Antifungal Agents
- (2020) Matthew A Miller et al. Open Forum Infectious Diseases
- Defining breakthrough invasive fungal infection–Position paper of the mycoses study group education and research consortium and the European Confederation of Medical Mycology
- (2019) Oliver A. Cornely et al. MYCOSES
- Antifungal synergy of a topical triazole, PC945, with a systemic triazole against respiratory Aspergillus fumigatus infection
- (2019) Thomas Colley et al. Scientific Reports
- Low central nervous system posaconazole concentrations during cerebral phaeohyphomycosis
- (2019) François Barde et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Matched-paired analysis of patients treated for invasive mucormycosis: standard treatment versus posaconazole new formulations (MoveOn)
- (2019) Jon Salmanton-García et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- 726. APX001 (Fosmanogepix) Is Effective in an Immunosuppressed Mouse Model of Rhizopus oryzae Infection
- (2019) Teklegiorgis Gebremariam et al. Open Forum Infectious Diseases
- Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium
- (2019) Oliver A Cornely et al. LANCET INFECTIOUS DISEASES
- Antifungal Prophylaxis with Posaconazole Delayed-Release Tablet and Oral Suspension in a Real-Life Setting: Plasma Levels, Efficacy, and Tolerability
- (2018) David Lenczuk et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline
- (2018) A.J. Ullmann et al. CLINICAL MICROBIOLOGY AND INFECTION
- Diagnosis of invasive aspergillosis in hematological malignancy patients: Performance of cytokines, Asp LFD, and Aspergillus PCR in same day blood and bronchoalveolar lavage samples
- (2018) Sven Heldt et al. JOURNAL OF INFECTION
- OUP accepted manuscript
- (2018) MEDICAL MYCOLOGY
- Isavuconazole treatment for rare fungal diseases and for invasive aspergillosis in patients with renal impairment: Challenges and lessons of the VITAL trial
- (2018) John R. Perfect et al. MYCOSES
- Spotlight on isavuconazole in the treatment of invasive aspergillosis and mucormycosis: design, development, and place in therapy
- (2018) Jeffrey D Jenks et al. Drug Design Development and Therapy
- Phase I trial to investigate the effect of renal impairment on isavuconazole pharmacokinetics
- (2017) Robert W. Townsend et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients
- (2017) Romuald Bellmann et al. INFECTION
- Inhibitory Potential of Antifungal Drugs on ATP-Binding Cassette Transporters P-Glycoprotein, MRP1 to MRP5, BCRP, and BSEP
- (2016) Vincent J. C. Lempers et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Population Pharmacokinetics of Isavuconazole in Subjects with Mild or Moderate Hepatic Impairment
- (2016) Amit Desai et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Posaconazole Plasma Concentrations on Days Three to Five Predict Steady-State Levels
- (2016) Jürgen Prattes et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Safety and Pharmacokinetics of CD101 IV, a Novel Echinocandin, in Healthy Adults
- (2016) Taylor Sandison et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
- (2016) Thomas F. Patterson et al. CLINICAL INFECTIOUS DISEASES
- Liposomal Amphotericin B (AmBisome®): A Review of the Pharmacokinetics, Pharmacodynamics, Clinical Experience and Future Directions
- (2016) Neil R. H. Stone et al. DRUGS
- ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients
- (2016) Frederic Tissot et al. HAEMATOLOGICA
- Isavuconazole absorption following oral administration in healthy subjects is comparable to intravenous dosing, and is not affected by food, or drugs that alter stomach pH
- (2016) Anne Schmitt-Hoffmann et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial
- (2016) Johan A Maertens et al. LANCET
- Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis
- (2016) Francisco M Marty et al. LANCET INFECTIOUS DISEASES
- Galactomannan testing andAspergillusPCR in same-day bronchoalveolar lavage and blood samples for diagnosis of invasive aspergillosis
- (2016) Susanne Eigl et al. MEDICAL MYCOLOGY
- ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients
- (2016) Frederic Tissot et al. HAEMATOLOGICA
- Safety and Pharmacokinetics of Isavuconazole as Antifungal Prophylaxis in Acute Myeloid Leukemia Patients with Neutropenia: Results of a Phase 2, Dose Escalation Study
- (2015) Oliver A. Cornely et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Azole Resistance inAspergillus fumigatus: Can We Retain the Clinical Use of Mold-Active Antifungal Azoles?
- (2015) Paul E. Verweij et al. CLINICAL INFECTIOUS DISEASES
- Influence of mould-active antifungal treatment on the performance of the Aspergillus-specific bronchoalveolar lavage fluid lateral-flow device test
- (2015) Susanne Eigl et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- ESCMID† and ECMM‡ joint clinical guidelines for the diagnosis and management of mucormycosis 2013
- (2014) O.A. Cornely et al. CLINICAL MICROBIOLOGY AND INFECTION
- Impact of structured personal on-site patient education on low posaconazole plasma concentrations in patients with haematological malignancies
- (2014) Martin Hoenigl et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Salvage combination antifungal therapy for acute invasive aspergillosis may improve outcomes: a systematic review and meta-analysis
- (2014) Anil A. Panackal et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- The role of surgical debridement in different clinical manifestations of invasive aspergillosis
- (2014) Frederike Reischies et al. MYCOSES
- Antifungal Pharmacokinetics and Pharmacodynamics
- (2014) A. J. Lepak et al. Cold Spring Harbor Perspectives in Medicine
- Potential Factors for Inadequate Voriconazole Plasma Concentrations in Intensive Care Unit Patients and Patients with Hematological Malignancies
- (2013) Martin Hoenigl et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antifungal Therapy of Aspergillosis of the Central Nervous System and Aspergillus Endophthalmitis
- (2013) Martin Hoenigl et al. CURRENT PHARMACEUTICAL DESIGN
- Caspofungin first-line therapy for invasive aspergillosis in allogeneic hematopoietic stem cell transplant patients: an European Organisation for Research and Treatment of Cancer study
- (2010) R Herbrecht et al. BONE MARROW TRANSPLANTATION
- Pharmacokinetic/Pharmacodynamic Profile of Posaconazole
- (2010) Yanjun Li et al. CLINICAL PHARMACOKINETICS
- Echinocandin Antifungal Drugs in Fungal Infections
- (2010) Sharon C.-A. Chen et al. DRUGS
- Posaconazole: clinical pharmacokinetics and drug interactions
- (2010) Hans-Peter Lipp MYCOSES
- Pulmonary Epithelial Lining Fluid Concentrations after Use of Systemic Amphotericin B Lipid Formulations
- (2009) S. Weiler et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- An EORTC Phase II study of caspofungin as first-line therapy of invasive aspergillosis in haematological patients
- (2009) C. Viscoli et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Combination Echinocandin-Polyene Treatment of Murine Mucormycosis
- (2008) A. S. Ibrahim et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Levels of amphotericin B lipid formulations in ascites
- (2008) S. Weiler et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now